人类胎盘超声微血管成像显示伴血管与免疫病理的胎儿生长受限中血管密度改变:一项先导性病例对照研究
本先导性病例对照研究纳入妊娠晚期胎儿生长受限(FGR)40例与胎龄匹配的正常胎儿生长对照20例(2:1),采用Verasonics Vantage超声系统行高灵敏度超声微血管成像(HUMI)测量胎盘血管密度(VD)。最终42例完成VD测量(平均孕35周5天),FGR组(n=24)胎盘VD较对照组显著降低(P<.01),VD预测FGR的效能与收缩期/舒张期(S/D)比值相当(AUC 0.86 vs 0.80);组织学诊断炎症性绒毛炎(n=10)的胎盘VD较无炎症者升高(P=.01),低VD与S/D比值升高相关(P=.03)。
要点
- FGR组胎盘VD较对照组显著降低(P<.01),VD预测FGR的AUC为0.86。
- VD预测FGR效能与S/D比值相当(AUC 0.86 vs 0.80)。
- 组织学诊断炎症性绒毛炎的胎盘VD较无炎症者升高(P=.01)。
核心结论
- HUMI可用于在体识别FGR中改变的胎盘血管化,VD可能是胎盘健康的有价值指标,并可能有助于考虑潜在生物学机制改进风险分层方法。
研究设计与样本
- 先导性病例对照研究,纳入妊娠晚期FGR 40例与胎龄匹配的正常胎儿生长对照20例(2:1),使用Verasonics Vantage超声系统行HUMI,采用基于随机奇异值分解的杂波滤波识别绒毛树并行逐步扫描获取类三维数据,每位受试者取三次超声测量计算平均VD,同时收集临床与病理资料进行比较。
关键影像表现/征象
- HUMI采用基于随机奇异值分解的杂波滤波识别绒毛树,并通过逐步扫描获取类三维数据。
- FGR组(n=24)胎盘VD较对照组显著降低(P<.01)。
- 组织学诊断炎症性绒毛炎(n=10)的胎盘VD较无炎症者升高(P=.01)。
- 低VD与S/D比值升高相关(P=.03)。
诊断标准与关键数值
- VD预测FGR的AUC为0.86,S/D比值预测FGR的AUC为0.80。
- 16例受试者用于建立扫描方案,2例在分娩时符合排除标准,最终42例成功测量VD,平均扫描孕周为35周5天。
临床应用与阅片要点
- HUMI可用于在体识别FGR中改变的胎盘血管化。
- VD可能是胎盘健康的指标,并可能有助于考虑潜在生物学机制改进风险分层方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Fetal growth restriction (FGR) is commonly associated with placental dysfunction, increasing perinatal morbidity and mortality. Visualizing placental vessels in utero would be advantageous for identifying functional FGR cause and determining proper management strategies. We aimed to utilize high-sensitivity ultrasound microvessel imaging (HUMI) for quantifying placental vessel density (VD) in pregnancies diagnosed with FGR.
METHODS: This pilot case-control study enrolled subjects in the third trimester with a diagnosis of FGR (n = 40) and gestational age-matched controls with normal fetal growth (n = 20) at a 2:1 ratio, respectively. The Verasonics Vantage ultrasound system was used to perform HUMI on each participant at one timepoint. Scanning involved randomized singular value decomposition-based clutter filtering to identify the villous tree, followed by step-by-step scanning to acquire 3-dimensional-like data. Mean VD was calculated from three ultrasound measurements per subject. Additional clinical and pathology data were also collected and compared.
RESULTS: Sixteen participants were utilized to establish the scanning protocol and 2 met exclusion criteria at delivery. Thus, VD was successfully measured on 42 pregnancies scanned at 35 weeks 5 days on average. In FGR (n = 24), placental VD was significantly reduced compared to controls (P < .01). VD measures were as good at predicting FGR as systolic/diastolic (S/D) ratios (area under the curve 0.86 versus 0.80). In a smaller cohort, VD in placentas with a diagnosis of inflammatory villitis (n = 10) by histology showed an increase in VD compared to those without inflammation (P = .01). Low VD was correlated with increased S/D ratios (P = .03).
CONCLUSIONS: HUMI is useful for identifying altered placental vascularization in utero for FGR. VD may be a valuable indicator for placental health and could lead to improved risk stratification methods considering underlying biology.
引用
- Lok UW, Scott HM, Tang S, et al. Ultrasound Microvessel Imaging of the Human Placenta Demonstrates Altered Vessel Densities in Fetal Growth Restriction With Vascular and Immune Pathologies: A Pilot Case-Control Study. J Ultrasound Med. 2024. PMID: 39422170. doi:10.1002/jum.16604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。